Interacting Drugs |
Hydrocortisone (systemic) vs Denosumab |
Security Level |
 |
Mechanism |
Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased. |
Management |
Monitor therapy |
Hydrocortisone (systemic) vs Denosumab
Post Review about Hydrocortisone (systemic) vs Denosumab Click here to cancel reply.
Other Interactions of Hydrocortisone (systemic)
Other Interactions of Denosumab
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.